Mufg Securities Americas Inc. Acquires Shares of 18,576 CVS Health Co. (NYSE:CVS)

Mufg Securities Americas Inc. acquired a new stake in CVS Health Co. (NYSE:CVS - Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The fund acquired 18,576 shares of the pharmacy operator's stock, valued at approximately $834,000.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in CVS. Whitebox Advisors LLC bought a new position in shares of CVS Health in the 4th quarter valued at $249,000. Hall Laurie J Trustee increased its stake in shares of CVS Health by 25,484.4% in the 4th quarter. Hall Laurie J Trustee now owns 11,513 shares of the pharmacy operator's stock valued at $517,000 after purchasing an additional 11,468 shares during the last quarter. B&D White Capital Company LLC bought a new position in shares of CVS Health in the 4th quarter valued at $417,000. Fairfax Financial Holdings Ltd. Can bought a new position in shares of CVS Health in the 4th quarter valued at $121,742,000. Finally, Seizert Capital Partners LLC increased its stake in shares of CVS Health by 22.8% in the 4th quarter. Seizert Capital Partners LLC now owns 569,527 shares of the pharmacy operator's stock valued at $25,566,000 after purchasing an additional 105,708 shares during the last quarter. 80.66% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on CVS shares. Royal Bank of Canada lifted their price target on CVS Health from $74.00 to $81.00 and gave the company an "outperform" rating in a research note on Monday, May 5th. UBS Group boosted their price objective on CVS Health from $67.00 to $71.00 and gave the stock a "neutral" rating in a research report on Friday, May 2nd. Wells Fargo & Company reaffirmed an "overweight" rating and issued a $84.00 target price (up previously from $76.00) on shares of CVS Health in a report on Tuesday, May 6th. Piper Sandler upped their target price on CVS Health from $72.00 to $74.00 and gave the stock an "overweight" rating in a report on Friday, March 21st. Finally, Cantor Fitzgerald raised CVS Health from a "neutral" rating to an "overweight" rating in a report on Wednesday, February 12th. Three investment analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $74.94.

Insiders Place Their Bets

In other news, Director Michael F. Mahoney purchased 30,000 shares of the business's stock in a transaction on Tuesday, February 18th. The shares were acquired at an average price of $66.70 per share, for a total transaction of $2,001,000.00. Following the completion of the acquisition, the director now owns 39,356 shares in the company, valued at approximately $2,625,045.20. The trade was a 320.65% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, SVP James David Clark sold 7,513 shares of the stock in a transaction that occurred on Wednesday, March 5th. The stock was sold at an average price of $66.35, for a total value of $498,487.55. Following the completion of the transaction, the senior vice president now owns 8,394 shares in the company, valued at approximately $556,941.90. The trade was a 47.23% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.22% of the company's stock.

CVS Health Stock Down 0.8%

Shares of CVS Health stock opened at $60.03 on Thursday. CVS Health Co. has a one year low of $43.56 and a one year high of $72.51. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.81 and a quick ratio of 0.60. The stock's 50-day moving average is $66.71 and its 200 day moving average is $59.15. The firm has a market cap of $75.94 billion, a price-to-earnings ratio of 16.40, a PEG ratio of 0.98 and a beta of 0.60.

CVS Health (NYSE:CVS - Get Free Report) last announced its earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 EPS for the quarter, beating the consensus estimate of $1.62 by $0.63. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. The company had revenue of $94.59 billion for the quarter, compared to analyst estimates of $93.07 billion. During the same quarter in the prior year, the company earned $1.31 EPS. The firm's revenue for the quarter was up 7.0% compared to the same quarter last year. Equities research analysts anticipate that CVS Health Co. will post 5.89 EPS for the current year.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, May 1st. Shareholders of record on Tuesday, April 22nd were issued a $0.665 dividend. The ex-dividend date was Tuesday, April 22nd. This represents a $2.66 annualized dividend and a yield of 4.43%. CVS Health's payout ratio is currently 63.48%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.